Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Muhammad Bulbul

1PUBLICATIONS

10CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Aug 25, 2025

Tetra-modality bladder preservation with avelumab for muscle-invasive urothelial cancer: a phase II trial (TRIUMPH-B01).

Ali Shamseddine, Noura Abbas, Sally Temraz

Pageof 1

Frequent Collaborators

1 joint publications

Ali Shamseddine

1 joint publications

Noura Abbas

1 joint publications

Sally Temraz

1 joint publications

Monita Al Darazi

1 joint publications

Maya Charafeddine

1 joint publications

Kristel Dagher

1 joint publications

Bassem Youssef

1 joint publications

Rami Nasr

1 joint publications

Raja Khauli

1 joint publications

Albert El Hajj

Frequent Collaborators

1 joint publications

Ali Shamseddine

1 joint publications

Noura Abbas

1 joint publications

Sally Temraz

1 joint publications

Monita Al Darazi

Top Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

See more related videos

Top Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

See more related videos